Literature DB >> 10070063

Inhibition of NO synthesis or endothelium removal reveals a vasoconstrictor effect of insulin on isolated arterioles.

C A Schroeder1, Y L Chen, E J Messina.   

Abstract

In this study we tested the hypothesis that insulin may differentially affect isolated arterioles from red (RGM) and white gastrocnemius muscles (WGM) because of their differences in function and metabolic profile. We also determined whether the responses of these arterioles are endothelium dependent and mediated by either prostaglandins or nitric oxide (NO). Arterioles were isolated, pressurized to 85 mmHg, equilibrated in Krebs bicarbonate-buffered solution (pH 7.4) gassed with 10% O2 (5% CO2-85% N2), and studied in a no-flow state. Control diameters for first-order arterioles from RGM averaged 77 +/- 8 micrometers and from WGM averaged 77 +/- 5 micrometers. Cumulative dose-response curves to insulin (10 microU/ml, 100 microU/ml, 1 mU/ml, and 10 mU/ml) were obtained in arterioles before and after endothelium removal or administration of either indomethacin (Indo, 10(-5) M) or NG-nitro-L-arginine (L-NNA, 10(-4) M). Insulin evoked concentration-dependent increases in control diameter of intact RGM and WGM arterioles of 6-26% and 9-28%, respectively. Indo was without any effect on insulin-induced dilation in RGM and WGM arterioles. Insulin-evoked dilation in both RGM and WGM arterioles was completely inhibited and converted to vasoconstriction by endothelium removal and administration of L-NNA. These results indicate that in endothelium-intact arterioles from RGM and WGM, insulin evokes an endothelium-dependent dilation that is equivalent and mediated by NO. In contrast, in the absence of a functional endothelium, insulin evokes arteriolar constriction. The finding that insulin can constrict arterioles, at physiological concentrations, suggests that insulin may play a more significant role in the regulation of vascular tone and total peripheral resistance than previously appreciated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10070063     DOI: 10.1152/ajpheart.1999.276.3.H815

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Vascular insulin resistance: a potential link between cardiovascular and metabolic diseases.

Authors:  Ivonne Hernandez Schulman; Ming-Sheng Zhou
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

2.  Insulin therapy does not interfere with venous endothelial function evaluation in patients with type 2 diabetes mellitus.

Authors:  Antônio Marcos Vargas da Silva; Luciana de Moraes Penno; Marcello Casaccia Bertoluci; Maria Cláudia Irigoyen; Beatriz D'Agord Schaan
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

Review 3.  Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle.

Authors:  Michael G Clark
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-08       Impact factor: 4.310

4.  Decreased NO signaling leads to enhanced vasoconstrictor responsiveness in skeletal muscle arterioles of the ZDF rat prior to overt diabetes and hypertension.

Authors:  Lisa A Lesniewski; Anthony J Donato; Bradley J Behnke; Christopher R Woodman; M Harold Laughlin; Chester A Ray; Michael D Delp
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-02-01       Impact factor: 4.733

5.  Cerebrovascular responses to insulin in rats.

Authors:  Prasad Venkateswera Gurunath Katakam; Ferenc Domoki; Laura Lenti; Tamás Gáspár; Adam Institoris; James Andy Snipes; David William Busija
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-02       Impact factor: 6.200

6.  Hypertension in metabolic syndrome: vascular pathophysiology.

Authors:  Yolanda Mendizábal; Silvia Llorens; Eduardo Nava
Journal:  Int J Hypertens       Date:  2013-03-20       Impact factor: 2.420

7.  Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?

Authors:  Fu-Shun Yen; Jung-Nien Lai; James Cheng-Chung Wei; Lu-Ting Chiu; Chih-Cheng Hsu; Ming-Chih Hou; Chii-Min Hwu
Journal:  BMC Gastroenterol       Date:  2021-06-12       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.